1
|
Bons J, Husson G, Chion M, Bonnet M, Maumy-Bertrand M, Delalande F, Cianférani S, Bertrand F, Picard B, Carapito C. Combining label-free and label-based accurate quantifications with SWATH-MS: Comparison with SRM and PRM for the evaluation of bovine muscle type effects. Proteomics 2021; 21:e2000214. [PMID: 33733615 DOI: 10.1002/pmic.202000214] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2020] [Revised: 03/06/2021] [Accepted: 03/08/2021] [Indexed: 11/11/2022]
Abstract
Mass spectrometry has proven to be a valuable tool for the accurate quantification of proteins. In this study, the performances of three targeted approaches, namely selected reaction monitoring (SRM), parallel reaction monitoring (PRM) and sequential windowed acquisition of all theoretical fragment ion mass spectra (SWATH-MS), to accurately quantify ten potential biomarkers of beef meat tenderness or marbling in a cohort of 64 muscle samples were evaluated. So as to get the most benefit out of the complete MS2 maps that are acquired in SWATH-MS, an original label-free quantification method to estimate protein amounts using an I-spline regression model was developed. Overall, SWATH-MS outperformed SRM in terms of sensitivity and dynamic range, while PRM still performed the best, and all three strategies showed similar quantification accuracies and precisions for the absolute quantification of targets of interest. This targeted picture was extended by 585 additional proteins for which amounts were estimated using the label-free approach on SWATH-MS; thus, offering a more global profiling of muscle proteomes and further insights into muscle type effect on candidate biomarkers of beef meat qualities as well as muscle metabolism.
Collapse
Affiliation(s)
- Joanna Bons
- Laboratoire de Spectrométrie de Masse BioOrganique, IPHC UMR7178, CNRS, Université de Strasbourg, Strasbourg, France
| | - Gauthier Husson
- Laboratoire de Spectrométrie de Masse BioOrganique, IPHC UMR7178, CNRS, Université de Strasbourg, Strasbourg, France
| | - Marie Chion
- Laboratoire de Spectrométrie de Masse BioOrganique, IPHC UMR7178, CNRS, Université de Strasbourg, Strasbourg, France.,Institut de Recherche Mathématique Avancée, Université de Strasbourg, Strasbourg, France
| | - Muriel Bonnet
- Université Clermont Auvergne, Saint-Genès-Champanelle, France
| | - Myriam Maumy-Bertrand
- Institut de Recherche Mathématique Avancée, Université de Strasbourg, Strasbourg, France
| | - François Delalande
- Laboratoire de Spectrométrie de Masse BioOrganique, IPHC UMR7178, CNRS, Université de Strasbourg, Strasbourg, France
| | - Sarah Cianférani
- Laboratoire de Spectrométrie de Masse BioOrganique, IPHC UMR7178, CNRS, Université de Strasbourg, Strasbourg, France
| | - Frédéric Bertrand
- Laboratoire de Modélisation et Sûreté des Systèmes, Institut Charles Delaunay, Université de Technologie de Troyes, Troyes, France
| | - Brigitte Picard
- Université Clermont Auvergne, Saint-Genès-Champanelle, France
| | - Christine Carapito
- Laboratoire de Spectrométrie de Masse BioOrganique, IPHC UMR7178, CNRS, Université de Strasbourg, Strasbourg, France
| |
Collapse
|
2
|
Husson G, Delangle A, O’Hara J, Cianferani S, Gervais A, Van Dorsselaer A, Bracewell D, Carapito C. Dual Data-Independent Acquisition Approach Combining Global HCP Profiling and Absolute Quantification of Key Impurities during Bioprocess Development. Anal Chem 2017; 90:1241-1247. [DOI: 10.1021/acs.analchem.7b03965] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Gauthier Husson
- Laboratoire
de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS,
IPHC, UMR 7178, F-67000 Strasbourg, France
| | - Aurélie Delangle
- Department
of Analytical Sciences Biologicals, UCB Pharma s.a., Chemin du
Foriest, B-1420 Braine L’alleud, Belgium
| | - John O’Hara
- Department
of Analytical Sciences Biologicals, UCB Pharma s.a., 216 Bath
Road, Slough SL1 4EN, U.K
| | - Sarah Cianferani
- Laboratoire
de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS,
IPHC, UMR 7178, F-67000 Strasbourg, France
| | - Annick Gervais
- Department
of Analytical Sciences Biologicals, UCB Pharma s.a., Chemin du
Foriest, B-1420 Braine L’alleud, Belgium
| | - Alain Van Dorsselaer
- Laboratoire
de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS,
IPHC, UMR 7178, F-67000 Strasbourg, France
| | - Dan Bracewell
- Dept.
Biochemical Engineering, University College London, Gower Street, London WC1E 6BT, U.K
| | - Christine Carapito
- Laboratoire
de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS,
IPHC, UMR 7178, F-67000 Strasbourg, France
| |
Collapse
|
3
|
Bordessa A, Colin-Cassin C, Grillier-Vuissoz I, Kuntz S, Mazerbourg S, Husson G, Vo M, Flament S, Martin H, Chapleur Y, Boisbrun M. Optimization of troglitazone derivatives as potent anti-proliferative agents: towards more active and less toxic compounds. Eur J Med Chem 2014; 83:129-40. [PMID: 24953030 DOI: 10.1016/j.ejmech.2014.06.015] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2014] [Revised: 05/16/2014] [Accepted: 06/09/2014] [Indexed: 11/25/2022]
Abstract
Δ2-Troglitazone derivatives were shown to exhibit anti-proliferative activity in a PPARγ-independent manner. We prepared various compounds in order to increase their potency and decrease their toxicity towards non-malignant primary cultured hepatocytes. Many compounds induced viabilities less than 20% at 10 μM on various cancer cell lines. Furthermore, five of them showed hepatocyte viability of 80% or more at 200 μM. In addition, compounds 17 and 18 exhibited promising maximum tolerated doses on a murine model, enabling future investigations.
Collapse
Affiliation(s)
- Andrea Bordessa
- Université de Lorraine, SRSMC, UMR 7565, BP 70239, F-54506 Vandœuvre-lès-Nancy, France; CNRS, SRSMC, UMR 7565, BP 70239, F-54506 Vandœuvre-lès-Nancy, France
| | - Christelle Colin-Cassin
- Université de Lorraine, CRAN, UMR 7039, BP 70239, F-54506 Vandœuvre-lès-Nancy Cedex, France; CNRS, CRAN, UMR 7039, BP 70239, F-54506 Vandœuvre-lès-Nancy Cedex, France
| | - Isabelle Grillier-Vuissoz
- Université de Lorraine, CRAN, UMR 7039, BP 70239, F-54506 Vandœuvre-lès-Nancy Cedex, France; CNRS, CRAN, UMR 7039, BP 70239, F-54506 Vandœuvre-lès-Nancy Cedex, France
| | - Sandra Kuntz
- Université de Lorraine, CRAN, UMR 7039, BP 70239, F-54506 Vandœuvre-lès-Nancy Cedex, France; CNRS, CRAN, UMR 7039, BP 70239, F-54506 Vandœuvre-lès-Nancy Cedex, France
| | - Sabine Mazerbourg
- Université de Lorraine, CRAN, UMR 7039, BP 70239, F-54506 Vandœuvre-lès-Nancy Cedex, France; CNRS, CRAN, UMR 7039, BP 70239, F-54506 Vandœuvre-lès-Nancy Cedex, France
| | - Gauthier Husson
- Université de Lorraine, CRAN, UMR 7039, BP 70239, F-54506 Vandœuvre-lès-Nancy Cedex, France; CNRS, CRAN, UMR 7039, BP 70239, F-54506 Vandœuvre-lès-Nancy Cedex, France
| | - Myriam Vo
- Université de Lorraine, SRSMC, UMR 7565, BP 70239, F-54506 Vandœuvre-lès-Nancy, France; CNRS, SRSMC, UMR 7565, BP 70239, F-54506 Vandœuvre-lès-Nancy, France
| | - Stéphane Flament
- Université de Lorraine, CRAN, UMR 7039, BP 70239, F-54506 Vandœuvre-lès-Nancy Cedex, France; CNRS, CRAN, UMR 7039, BP 70239, F-54506 Vandœuvre-lès-Nancy Cedex, France
| | - Hélène Martin
- Université de Franche-Comté, Laboratoire de Toxicologie Cellulaire, EA 4267, 25030 Besançon Cedex, France
| | - Yves Chapleur
- Université de Lorraine, SRSMC, UMR 7565, BP 70239, F-54506 Vandœuvre-lès-Nancy, France; CNRS, SRSMC, UMR 7565, BP 70239, F-54506 Vandœuvre-lès-Nancy, France
| | - Michel Boisbrun
- Université de Lorraine, SRSMC, UMR 7565, BP 70239, F-54506 Vandœuvre-lès-Nancy, France; CNRS, SRSMC, UMR 7565, BP 70239, F-54506 Vandœuvre-lès-Nancy, France.
| |
Collapse
|
4
|
Somkin CP, Ackerson LM, Husson G, Kolevska T, Goldstein D, Fehrenbacher L. Predictors of accrual to clinical trials in an integrated health care delivery system. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.6093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
5
|
Vilagines P, Sarrette B, Husson G, Vilagines R. Définition des conditions optimales d'adsorption du poliovirus type 1 sur de la laine de verre sodo-calcique : application à des eaux de distribution et des eaux résiduaires. ACTA ACUST UNITED AC 2010. [DOI: 10.1051/water/19922301101] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
6
|
Abstract
The authors sought to examine the hypothesis that girls who were relatively tall during the prepubescent period (indicative of an affluent diet and good general health) were at increased risk of subsequent breast cancer. They conducted a case-control study of 214 long-term members who were diagnosed with breast cancer during 1973-1995 and who were age 12 years or younger when they first joined Kaiser Permanente and of 214 appropriately matched controls. Information was obtained from the medical records. While the authors observed the expected association of adult height with risk of breast cancer (height at age 15-18 years, tall-for-age vs. short-for-age: odds ratio = 2.2, 95% confidence interval: 1.1, 4.3), the association was no stronger earlier in life (height at age 9-11 years: odds ratio = 1.0, 95% confidence interval: 0.5, 1.8). The study does not support a relation between pubertal skeletal growth and adult risk of breast cancer. However, it is limited by the inclusion of few postmenopausal women.
Collapse
Affiliation(s)
- L J Herrinton
- Division of Research, Kaiser Permanente, 3505 Broadway, Oakland CA 94611-5714, USA.
| | | |
Collapse
|
7
|
Husson G, Herrinton LJ. How accurately does the medical record capture maternal history of cancer? Cancer Epidemiol Biomarkers Prev 2000; 9:765-8. [PMID: 10919750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2023] Open
Abstract
We sought to assess the reliability of information regarding the maternal history of cancer by comparing the medical records of 214 women with breast cancer, ages 26-59 years and diagnosed in 1974-1995, and of their controls with the medical records of their mothers. Subjects were members of Kaiser Permanente, Northern California, selected for a study of early-life predictors of breast cancer. For any type of cancer identified in the mother's medical record, the proportion noted in the daughter's medical record at least 6 months before the daughter's diagnosis or reference date was 56% among cases and 32% among controls. The odds ratio for the association of maternal cancer history with breast cancer risk was 2.1 using the maternal record and 3.5 using the subject's record. For a maternal history of breast cancer, the proportion noted in the subject's record was 79% among cases and 57% among controls, and the odds ratios were 4.0 and 6.5, respectively. We believe that the case-control difference in missing information was attributable to higher utilization of breast cancer screening among cases. This study illustrates the need to assess the impact of screening differences on the ascertainment of information from the medical records.
Collapse
Affiliation(s)
- G Husson
- Division of Research, Kaiser Permanente, Oakland, California 94611, USA.
| | | |
Collapse
|
8
|
Abstract
A case-control study design was used to examine whether habitual physical activity prior to the final menstrual period (FMP) was associated with reduced risk of vasomotor and other symptoms during the perimenopausal period. Both cases and controls were identified through a screening interview with randomly selected women members, ages 48-52, of a large health maintenance organization. Cases (n = 82) were defined as women 3-12 months past their FMP who reported regularly having hot flashes or night sweats at least once a day or night during the 3 months following their FMP. Controls (n = 89) were of the same biologic age with respect to the FMP but reported vasomotor symptoms less than once a week during the reference time period. Neither cases nor controls had a history of hormone replacement therapy (HRT), hysterectomy, or bilateral oophorectomy. Case-control status, habitual physical activity (including recreational, housework, child care, and occupational activity), and psychological and somatic symptoms were assessed by self-report. Participation in vigorous recreational activity during the year prior to the FMP was not associated with reduced risk of frequent vasomotor symptoms after the FMP (odds ratio [OR] = 1.03 for a 50-unit increase in activity score, 95% confidence interval [CI] = 0.97-1.1). This lack of relationship was observed in all domains of activity. Factors that were associated with decreased risk included higher body mass index (BMI) (weight in kg/(height in meters)2) (OR = 0.95 per 1 unit increase in BMI, 95% CI = 0.90-1.00) and higher education (having a college degree relative to less education) (OR = 0.56, 95% CI = 0.40-0.80). Physical activity was also unassociated with reduced risk of psychologic distress, depressive feelings, or somatic symptoms, but, relative to controls, having vasomotor symptoms (being a case) was strongly associated with increased risk of experiencing those symptoms (OR ranging from 1.83 for psychologic distress to 2.84 for depressive feelings). These findings suggest that regular physical activity before the FMP may not reduce the likelihood of experiencing symptoms during the perimenopause, although the small sample size may limit the inferences that can be drawn.
Collapse
Affiliation(s)
- B Sternfeld
- Department of Epidemiology and Biostatistics, Kaiser Permanente Medical Care Program, Oakland, California 94611, USA
| | | | | |
Collapse
|
9
|
Johnson LW, Fishman RA, Schneider B, Parker FB, Husson G, Webb WR. Familial supravalvular aortic stenosis. Report of a large family and review of the literature. Chest 1976; 70:494-500. [PMID: 975952 DOI: 10.1378/chest.70.4.494] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Familial supravalvular aortic stenosis has been recognized as a distinct syndrome. A large family with five proven cases and a review of the literature on familial supravalvular aortic stenosis are presented. The diagnosis was substantiated in all 63 cases by cardiac catheterization, surgery, or postmortem examination.
Collapse
|